AUPQ585500A0 - Treatment for peripheral sensory neuropathy - Google Patents

Treatment for peripheral sensory neuropathy

Info

Publication number
AUPQ585500A0
AUPQ585500A0 AUPQ5855A AUPQ585500A AUPQ585500A0 AU PQ585500 A0 AUPQ585500 A0 AU PQ585500A0 AU PQ5855 A AUPQ5855 A AU PQ5855A AU PQ585500 A AUPQ585500 A AU PQ585500A AU PQ585500 A0 AUPQ585500 A0 AU PQ585500A0
Authority
AU
Australia
Prior art keywords
treatment
sensory neuropathy
peripheral sensory
peripheral
neuropathy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPQ5855A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes Biopharma AU Ltd
Original Assignee
Gropep Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gropep Ltd filed Critical Gropep Ltd
Priority to AUPQ5855A priority Critical patent/AUPQ585500A0/en
Publication of AUPQ585500A0 publication Critical patent/AUPQ585500A0/en
Priority to PCT/AU2001/000191 priority patent/WO2001062277A1/en
Priority to AU2001235253A priority patent/AU2001235253A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AUPQ5855A 2000-02-25 2000-02-25 Treatment for peripheral sensory neuropathy Abandoned AUPQ585500A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPQ5855A AUPQ585500A0 (en) 2000-02-25 2000-02-25 Treatment for peripheral sensory neuropathy
PCT/AU2001/000191 WO2001062277A1 (en) 2000-02-25 2001-02-23 Treatment for peripheral sensory neuropathy
AU2001235253A AU2001235253A1 (en) 2000-02-25 2001-02-23 Treatment for peripheral sensory neuropathy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPQ5855A AUPQ585500A0 (en) 2000-02-25 2000-02-25 Treatment for peripheral sensory neuropathy

Publications (1)

Publication Number Publication Date
AUPQ585500A0 true AUPQ585500A0 (en) 2000-03-16

Family

ID=3819963

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPQ5855A Abandoned AUPQ585500A0 (en) 2000-02-25 2000-02-25 Treatment for peripheral sensory neuropathy

Country Status (2)

Country Link
AU (1) AUPQ585500A0 (en)
WO (1) WO2001062277A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015095650A1 (en) 2013-12-19 2015-06-25 Puretein Bioscience Llc. Methods for treating an animal

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0686040A1 (en) * 1993-01-29 1995-12-13 Amgen Boulder Inc. Wound healing composition
AU2917495A (en) * 1994-07-13 1996-02-16 Gropep Pty Ltd Use of insulin-like growth factor in combination with insulin
WO1999018946A1 (en) * 1997-10-14 1999-04-22 Tatton Nadine A Methods for increasing schwann cell survival
AU762047B2 (en) * 1999-01-06 2003-06-19 Genentech Inc. Insulin-like growth factor (IGF) I mutant variants

Also Published As

Publication number Publication date
WO2001062277A1 (en) 2001-08-30

Similar Documents

Publication Publication Date Title
AU2002223827A1 (en) Well treatment
AU2001260513A1 (en) Microcapsule well treatment
AUPQ514600A0 (en) Brain injury treatment
AU2001261262A1 (en) Glaucoma treatment device
AU2001245792A1 (en) Proning bed
AU2002216959A1 (en) Fabric treatment device
AU2002215125A1 (en) Well treatment method
EG25829A (en) Novel treatment
AU2002324201A1 (en) Waste treatment
GB0030845D0 (en) Novel treatment
AU2002236781A1 (en) Treatment for snoring
AU2001253568A1 (en) Lipopolysaccharide-conjugate vaccine for sepsis treatment
AU2001236929A1 (en) Surface treatment
AU2002228563A1 (en) Bed
AU2002225327A1 (en) Apparatus for aesthetic treatment
AU2001261324A1 (en) Psoriasis treatment
AU2002221760A1 (en) Vaccine for treating allergy
AU2001282349A1 (en) Fluid treatment
AUPQ585500A0 (en) Treatment for peripheral sensory neuropathy
AU2001235253A1 (en) Treatment for peripheral sensory neuropathy
AU2002343059A1 (en) Bed
GB0031321D0 (en) Treatment
GB0029125D0 (en) Novel treatment
AU2001289127A1 (en) Tumor treatment
AU2002349330A1 (en) Yarn treatment device

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 3525301

Country of ref document: AU